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Scope: Obesity is closely related to the imbalance of white adipose tissue storing excess calories,
and brown adipose tissue dissipating energy to produce heat in mammals. Recent studies
revealed that acquisition of brown characteristics by white adipocytes, termed “browning,” may
positively contribute to cellular bioenergetics and metabolism homeostasis. The goal was to
investigate the putative effects of natural antioxidant sulforaphane (1-isothiocyanate-4-methyl-
sulfonyl butane; SFN) on browning of white adipocytes.
Methods and results: 3T3-L1mature white adipocytes were treated with SFN for 48 h, and then
the mitochondrial content, function, and energy utilization were assessed. SFN was found
to induce 3T3-L1 adipocytes browning based on the increased mitochondrial content and
activity of respiratory chain enzymes, whereas the mechanism involved the upregulation of
nuclear factor E2-related factor 2/sirtuin1/peroxisome proliferator activated receptor gamma
coactivator 1 alpha signaling. SFN enhanced uncoupling protein 1 expression, a marker for
brown adipocyte, leading to the decrease in cellular ATP. SFN also enhanced glucose uptake
and oxidative utilization, lipolysis, and fatty acid oxidation in 3T3-L1 adipocytes.
Conclusion: SFN-induced browning of white adipocytes enhanced the utilization of cellular
fuel, and application of SFN is a promising strategy to combat obesity and obesity-related
metabolic disorder.
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1 Introduction
Mammals have two types of adipose tissue: white adipose
tissue (WAT) and brown adipose tissue, which are mainly
composed of white adipocytes and brown adipocytes,
respectively. The abnormal accumulation of WAT in obese
Sirt-1/PGC-1, sirtuin1/peroxisome proliferator activated recep-
tor gamma coactivator 1 alpha; TG, triacylglyceride; UCP1, un-
coupling protein 1;WAT, white adipose tissue
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patients is caused by an imbalance in energy intake and
energy expenditure, and is thought to be a bridge between
obesity and its related complications, such as type 2 diabetes
and cardiovascular disease [1]. White adipocytes are special-
ized to store excess energy in the form of triacylglycerols, and
as an important endocrine organ, WAT directly modulates
metabolism by secreting various adipokines. In contrast,
brown adipocytes, which are characterized by a large number
of mitochondria containing uncoupling protein 1 (UCP1),
directly dissipate calories as heat via uncoupling of the elec-
tron transport chain from ATP synthesis [2]. In recent years,
inducible beige adipocytes have been found within WAT
in response to cold or -adrenergic stimulation [3, 4]. This
novel type of adipocytes shares biochemical features, such as
displaying multilocular lipid droplets and comparable levels
of UCP1 protein, and thermogenic potential that is similar to
classical brown adipocytes; therefore, these adipocytes have
been termed “beige” adipocytes. The inducibility of beige
adipocytes via pharmacological and nutritional intervention
positions these cells as an attractive target of obesity thera-
peutics [5]. The process of conversion of white adipocytes into
beige adipocytes is called “browning,” and recent research has
increasingly become focused on understanding this brown-
ing of adipose tissue. As adipose tissue plays an important
role in the uptake and utilization of glucose and lipids, whole-
body metabolism disorder is closely related to adipose tissue
dysfunction; however, cellular evidence that browning influ-
ences glucose and lipid metabolism in adipocytes is lacking.
The transcription factor nuclear factor E2-related factor
2 (Nrf2)/antioxidant response element (ARE) pathway de-
fends cells against elevated oxidative damage. Recent data
have clearly shown that energy metabolism is linked to cel-
lular redox balance control at the nuclear level via Nrf2, and
activation of the Nrf2-ARE pathway allows for elevated en-
ergy utilization. For instance, acetyl-L-carnitine was reported
to induce mitochondrial biogenesis in an Nrf2-dependent
manner [6]. In addition, mice treated with the potent Nrf2
inducer CDDO-IM exhibit higher energy expenditure com-
pared with untreated mice when fed a high-fat diet [7]. These
findings suggest the possibility that other dietary Nrf2 acti-
vators, such as sulforaphane (SFN), may also have effects on
cellular energy expenditure. SFN, which is a major isothio-
cyanate present in broccoli and other cruciferous vegetables,
exhibits potent antioxidant, Nrf2 agonist, and anticancer ef-
fects. The role of SFN in obesity therapy, however, remains
unclear.
Here, we investigated the effect of SFN on mitochondrial
biogenesis, UCP1 expression, and mitochondrial function in
mature 3T3-L1 adipocytes in order to elucidate the underly-
ing mechanism. Moreover, we also analyzed the glucose and
lipid metabolism in SFN-treated 3T3-L1 adipocytes. Our data
revealed that SFN induces the browning of 3T3-L1 white
adipocytes by promotingmitochondrial biogenesis via upreg-
ulation of sirtuin1/peroxisome proliferator activated receptor
gamma coactivator 1 alpha (Sirt-1/PGC-1) signaling and
enhancement of mitochondrial function. Furthermore, these
results also demonstrate that glucose uptake and oxidative
utilization, lipolysis, and fatty acid (FA) oxidation are
upregulated in SFN-treated 3T3-L1 adipocytes. In sum, our
results clearly identify SFN as a potential agent for protecting
against obesity and the related glucose and lipid metabolism
disorders by the induction of adipocyte browning.
2 Materials and methods
2.1 Materials
3T3-L1 cells were obtained from the American Type Culture
Collection (Manassas, VA, USA). D, L-SFN was purchased
from Toronto Research Chemical, Inc. (Toronto, Canada).
The details of the remaining reagents can be found in the
Supporting Information.
2.2 Cell culture and adipocyte differentiation
Murine 3T3-L1 preadipocytes were induced to differentiate
into mature adipocytes by classic cocktail method. Various
concentrations of SFN (0, 0.2, 0.5, 1, 5, and 10 M) were used
to treat the mature adipocytes. The detailed method can be
found in the Supporting Information.
2.3 Oil Red O staining
Oil Red O staining was used to assess mature adipocytes and
measure the lipid content in these cells. The detailed method
can be found in the Supporting Information.
2.4 Mitochondrial mass measurement
The matured 3T3-L1 adipocytes were treated with SFN or
left untreated for 48 h; MitoTracker Green FM (Beyotime
Biotechnology, Jiangsu, China), a mitochondria-specific dye,
was used to determine the mitochondrial mass. The detailed
method can be found in the Supporting Information.
2.5 Electron microscopy
Fully differentiated adipocytes were treated with 1 M SFN
or left untreated for 48 h. After a series of treatment, the
mitochondria number and the total cytoplasmic area in cells
were determined under electron microscopy. The detailed
method can be found in the Supporting Information.
2.6 Citrate synthase activity detection
Citrate synthase (CS) activity of adipocytes was measured
using the kit available from Sigma, the detailed method can
be found in the Supporting Information.
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2.7 Mitochondrial complex I activity measurement
Mature adipocytes, grown in 60-mm culture dishes, were
treated with SFN for 48 h, and mitochondrial complex I
activity was measured using the complex I enzyme activity
microplate assay kit. The detailed method can be found in
the Supporting Information.
2.8 Glucose uptake analysis
The fluorescent D-glucose analog 2-(N-(7-nitrobenz-2-oxa-1,3-
diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) was used as a
fluorescent indicator to evaluate glucose uptake in adipocytes
treated with SFN for 48 h. The fluorescence intensity at 465
nm was read using a fluorescent microplate reader to quan-
titate glucose uptake after 2-NBDG incubation. The detailed
method can be found in the Supporting Information.
2.9 Lipolysis assay
The release of glycerol into the culture media was detected
using glycerol colorimetric assay kit to evaluate the effect of
SFN on lipolysis of adipocytes. The detailed method can be
found in the Supporting Information.
2.10 Real-time quantitative PCR
3T3-L1 adipocytes were treated with SFN or left untreated for
48 h. Total RNA was isolated from 3T3-L1 mature adipocytes,
and then real-time quantitative PCR analysis was used to
evaluate the relative mRNA levels of acetyl-CoA carboxylase
(ACC) and fatty acid synthase (FAS). The detailedmethod can
be found in the Supporting Information.
2.11 Western blot analysis
Mature adipocytes were treated with SFN or left untreated
for 48 h, and the levels of indicated proteins were measured
by Western blot. The detailed method can be found in the
Supporting Information.
2.12 Intracellular ATP determination
CellTiter-GloLuminescent Cell Viability Assay system
(Promega Corporation, Beijing, China) was used to detect
the levels of ATP in adipocytes treated with or without SFN
for 48 h. ATP level was presented as relative light unit (RLU)
adjusted by cell number for either control or SFN-treated
cells. The detailed method can be found in the Supporting
Information.
2.13 Statistical analysis
All data are representative of at least three independent ex-
periments. Data are expressed as means ± SD. Statistical
evaluation was performed using one-way ANOVA with the
Students–Newman–Keuls test. pValues of less than 0.05were
considered statistically significant.
3 Results
3.1 SFN increases adipocyte mitochondrial
biogenesis in association with regulation of the
Nrf2/Sirt-1/PGC-1 pathway
Ten days after differentiation (D10) was initiated, >95% of
3T3-L1 preadipocytes were mature adipocytes containing Oil
Red O positive lipid droplets. The mature adipocytes were
then treated with SFN (0, 0.2, 0.5, 1, 5, and 10 M) for 48 h.
To accurately assess the mitochondrial content, MitoTracker
Green FM was used to stain mitochondria in live cells. SFN
treatment resulted in an increase in fluorescence intensity,
with a maximum in adipocytes treated with 1 M SFN
(Fig. 1A). To further confirm the beneficial effects of SFN
on mitochondrial biogenesis, we examined adipocyte mor-
phology in more detail using electron microscopy (Fig. 1B).
Quantitative analysis showed that SFN (1 M) treatment
caused a significant increase in mitochondrial intensity (i.e.,
the average number of mitochondria in the total cytoplasmic
area per cell) compared with control treatment (Fig. 1C;
p < 0.05). We also examined the Sirt-1/PGC-1 pathway to
clarify the underlying mechanism for the increased mito-
chondrial biogenesis. Sirt-1 was significantly increased in
SFN-treated adipocytes (Fig. 2; p < 0.05). Interestingly, Sirt-1
protein expression was most enhanced in adipocytes treated
with 1 M SFN. PGC-1, a downstream target of Sirt-1, was
also significantly increased in the adipocytes treated with
SFN (0, 0.2, 0.5, 1, 5, and 10 M; p < 0.05). Furthermore, the
level of nuclear respiratory factor 1 (NRF-1) protein, which
is a downstream target of PGC-1, significantly increased,
similar to PGC-1 (p < 0.05). In addition, SFN treatment
markedly increased the Nrf2 protein level (p < 0.05).
3.2 SFN increases adipocyte mitochondrial activity
and the expression of UCP1
To confirm whether the increased mitochondrial biogenesis
was associated with elevated mitochondrial activity, we first
examined the effect of SFN on CS, a marker of mitochon-
drial aerobic capacity. As shown in Fig. 3A, SFN treatment
markedly increased the activity of CS withmaximum enzyme
activity observed at an SFN concentration of 1 M. Simi-
larly, SFN also significantly elevated the activity of mitochon-
drial complex I on the respiratory chain (p < 0.05; Fig. 3B).
To further evaluate mitochondrial function, the level of
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Figure 1. Effect of SFN on the mitochondrial content of mature 3T3-L1 adipocyte. The cells were treated with 0, 0.2, 0.5, 1, 5, and 10 M
SFN for 48 h. (A) The mitochondrial mass was obtained using the Mitotracker Green stain (magnification, ×60). (B) The mitochondrial
ultrastructure image was generated using a transmission electron microscope (magnification, ×5,000). (C) The mitochondria density in
adipocytes was detected using a transmission electron microscope. Values indicate means ± SD of six cells. *p < 0.05 compared with the
control.
intracellular ATP was also measured. Accordingly, SFN in-
duced a decrease in the ATP level (Fig. 3C). Next, Western
blot analysis revealed that the expression of UCP1, a specific
brown adipocyte protein, in 3T3-L1 white adipocytes exposed
to SFN was markedly induced (p < 0.05) with a maximal
UCP1 protein expression at 1 M SFN (Fig. 4).
3.3 SFN stimulates glucose uptake, enhanced
glucose aerobic oxidation related gene
expression and inhibits de novo FA synthesis
related gene expression
The fluorescent nontoxic D-glucose analog 2-NBDG is
commonly used as a probe indicator for the rapid and direct
detection of glucose uptake into cells. Thus, we employed
2-NBDG for the detection of glucose uptake in mature
3T3-L1 adipocytes exposed to different doses of SFN for 48
h. The fluorescence intensity of 2-NBDG was qualitatively
and quantitatively measured using confocal microscopy and
a multifunctional microplate reader, respectively. Confocal
microscopy revealed that SFN induced glucose uptake in
adipocytes, with a maximum in adipocytes treated with 1 M
SFN (Fig. 5A). The quantitative results confirmed this trend
(Fig. 5B). Additionally, glucose transporter type 4 (GLUT-4)
is a glucose transporter expressed in adipose tissue and is
responsible for the transport of glucose into adipocytes. SFN
treatment markedly increased the expression of GLUT-4
(Fig. 5C). After being transported into adipocytes, glucose is
normally converted into pyruvate via the glycolytic pathway
mediated by hexokinase or glucokinase (GCK), while pyru-
vate is subsequently transferred into the mitochondria for
conversion into acetyl-CoA. Most of the acetyl-CoA enters the
tricarboxylic acid cycle to generate energy via the action of CS.
Conversely, acetyl-CoA that is derived from glucose and FA
oxidation may return to the cytosol to participate in de novo
synthesis of FAs via key enzymes, such as ACC and FAS.
In this study, the protein and mRNA levels of key enzymes
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Figure 2. Effects of SFN on the expression of Sirt-1, PGC-1, NRF-
1, and Nrf2 in 3T3-L1 mature adipocytes treated with the indi-
cated concentrations of SFN for 48 h. (A) Representative Western
blots. (B) Relative quantitative analysis of proteins. Results are
presented as percentages relative to control cells. Data are shown
as means ± SD of three independent experiments. *p < 0.05, **p
< 0.01 compared with the control.
involved in glucose aerobic oxidation, including GCK and
CS, as well as key enzymes involved in FA synthesis, such
as ACC and FAS, were measured in 3T3-L1 adipocytes using
Western blot and real-time quantitative PCR, respectively;
this was done in order to examine the mechanism used by
SFN to direct the metabolic fate of glucose in cells. Results
of Western blotting showed that the levels of GCK and
CS, indispensable to glucose oxidation, were significantly
upregulated in beige adipocytes induced by SFN (Fig. 5C; p
< 0.05),while real-time PCR indicated that the expression of
ACC and FAS genes, key enzymes involved in endogenous
synthesis of FAs was significantly inhibited (Fig. 5D).
3.4 SFN increases lipolysis, elevates the expression
of genes responsible for FA oxidation, and
decreases the protein level associated with
triacylglyceride synthesis
The effect of SFN on lipolysis in 3T3-L1 adipocytes was mea-
sured by quantifying the intracellular lipid content using Oil
Red O staining and by monitoring the output of glycerol
into the medium. SFN triggered an increase of lipolysis de-
picted by a bell-shaped curve with a minimal lipid content
Figure 3. Effect of SFN on mitochondrial function. Mature 3T3-
L1 adipocytes were treated with the indicated concentrations of
SFN for 48 h. (A) CS enzyme activity. (B) Mitochondrial complex
I activity. (C) The intracellular ATP level. Results are presented as
percentages relative to control. Values are means ± SD of three
experiments. *p < 0.05 compared with control.
corresponding to 1 and 5 M SFN (Fig. 6A and B) and a
maximal glycerol release corresponding to 1 M SFN (Table
1, Fig. 6C). Further, the expression of lipid metabolism re-
lated enzymes in adipocytes was examined. Triacylglyceride
(TG) is the main storage lipid in adipocytes. Lipolysis is a
step-wise process regulated by perilipin (Plin), adipose triacyl-
glyceride lipase (ATGL), and hormone-sensitive lipase (HSL).
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Figure 4. Effects of SFN on the expression of UCP1 inmature 3T3-
L1 adipocytes treated with SFN for 48 h. Upper: representative
Western blot. Lower: quantification of UCP 1 protein expression.
Results are presented as percentages relative to the control. Data
are means ± SD of three independent experiments. *p < 0.05,
**p < 0.01 compared with the control.
Plin is exclusively located on the surface layer of intracellular
lipid droplets within adipocytes, and functions to protect lipid
storage droplets. ATGL initiates the hydrolysis of TG into di-
acylglycerol (DAG) and free FAs, while HSL subsequently
catalyzes the release of one additional FA from DAG. Our
results demonstrated that both Plin and HSL protein expres-
sion in SFN-treated adipocytes was significantly decreased
compared with the levels in untreated adipocytes (p < 0.01),
whereas ATGL protein levels were not significantly elevated,
although a tendency for levels to increase was noted (Fig. 7).
Phosphorylation of HSL at Ser 563 and Ser 660, as stimu-
lated by protein kinase A (PKA), led to HSL translocation to
the surface of lipid droplets to promote lipolysis; however,
HSL phosphorylation at Ser 565 prevents phosphorylation of
HSL at Ser 563 [8]. In our study, SFN increased phosphory-
lation of HSL at Ser 563 and Ser 660 and decreased phos-
phorylation at Ser 565. Therefore, these findings suggest that
in SFN-induced beige adipocytes, lipolysis is primarily medi-
ated by Plin and HSL. Enhanced lipolysis of adipocytes may
lead to an increase of free FA release, and excess circulating
free FAs from the lipolysis of TG stored in white adipocytes
are harmful even at relatively low concentrations, resulting in
stimulation of macrophages and ultimately inflammation [9].
Therefore, an increase in the aerobic oxidation of FAs
in adipocytes will be helpful in inhibiting the influx of free
FAs into the bloodstream. Carnitine palmitoyltransferase
1A (CPT1A) and CS are key enzymes responsible for the
aerobic oxidation of FAs. CPT1A is responsible for shuttling
long-chain FAs into mitochondria, whereas CS functions
to initiate the tricarboxylic acid cycle. In the present study,
SFN treatment for 48 h induced increases in CPT1A and
CS expression (Fig. 8A). CPT1A increase suggested that FA
-oxidation was increased in SFN-induced beige adipocytes.
In addition, in order to examine whether SFN affect the
esterification of FAs for the synthesis of TG, the level
of diacylglycerol acyl transferase (DGAT-1) in adipocytes
incubated with SFN for 48 h was measured. DGAT-1 is
a crucial enzyme that is involved in catalysis of the final
step of triglyceride synthesis. In this study, DGAT-1 protein
expression was significantly decreased in SFN-treated cells
compared with expression in control cells (Fig. 8B; p < 0.01).
4 Discussion
SFN is a naturally occurring organo-sulfur compound de-
rived from cruciferous vegetables such as broccoli, brussels
sprouts, or cabbages [10]. SFN is a well-known potent natural
oxidant with anticancer properties [11]. SFN has also been
demonstrated to inhibit adipogenesis, and improve glucose
metabolism by blocking streptozotocin-induced islet destruc-
tion [12, 13]. Our previous study demonstrated that SFN can
induce the apoptosis of adipocyte [14]. Until now, however,
little has been known about the impact of SFN on mitochon-
dria homeostasis in adipocytes. As a result, we sought to in-
vestigate the effect of SFN on mitochondrial biogenesis and
UCP1 expression inmature 3T3-L1 adipocytes.We found that
SFN strongly impacted mitochondria biogenesis and func-
tion, leading to increasedmitochondrial content and oxidative
capacity, and ultimately inducing white adipocyte browning.
Additional data confirmed that SFN significantly enhanced
the activity of CS andmitochondrial complex enzymes on the
respiratory chain. More importantly, SFN markedly elevated
the expression of UCP1, which is a specific protein of brown
adipocyte. The cellular ATP content was decreased with the
elevation of UCP1 protein level. These results indicated that
SFN functions to promote the browning of adipocytes and
dissipate of ATP.
To explore the mechanism responsible for this effect of
SFN on 3T3-L1 adipocytes, the PGC-1 pathway was exam-
ined. PGC-1 is a transcriptional coactivator that plays an
important role in mitochondrial biogenesis in mammalian
tissues [15]. NRF-1 is an initial transcription factor target that
was identified in the induction ofmitochondrial biogenesis by
PGC-1, as manifested by PGC-1-induced transactivation
of NRF-1 and stimulation of mitochondrial DNA replication
and gene expression [16]. In contrast, a dominant-negative
allele of NRF-1 blocks the effects of PGC-1 on mitochon-
drial biogenesis [17]. Sirt-1, an NAD+-dependent protein
deacetylase, has emerged as an important metabolic sensor,
and its activation by small molecules, calorie restriction, or
exercise promotes mitochondrial biogenesis and activities
[18, 19]. PGC-1 is a principal substrate of Sirt-1, and
thus, Sirt-1 may function, in part, by deacetylating multiple
lysine residues in PGC-1, thereby upregulating metabolic
signaling through PGC-1 and promoting mitochondrial FA
oxidation [20]. As shown in our experiments, expressions of
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Figure 5. Effect of SFN on glucose uptake, aerobic oxidation, and de novo FA synthesis in 3T3-L1 adipocytes. Mature adipocytes were
incubated in the presence of 0–10 MSFN for 48 h. Glucose uptake wasmonitored using 2-NBDG as a fluorescent probe. (A) Representative
images of glucose uptake were captured by confocal microscopy. (B) Quantitative analysis of fluorescence intensity was determined using
multifunctional microplate reader. (C) Expressions of membrane protein GLUT-4 and glucose oxidative metabolism enzymes GCK and CS
were measured using Western blot. Upper: representative Western blot. Lower: quantification of proteins levels. (D) The mRNA levels of
the de novo FA synthesis enzymes ACC and FAS were determined by real-time quantitative PCR. Results are presented as percentages
relative to the control. Data are means ± SD of three independent experiments. *p < 0.05, **p < 0.01 compared with the control.
the transcription factors Sirt-1, PGC-1, and NRF-1, which
are involved in mitochondrial biogenesis, were upregulated
by SFN treatment in 3T3-L1 adipocytes. Moreover, this
upregulation was closely correlated with the stimulation of
mitochondrial biogenesis and induction of UCP1 expression,
suggesting that SFN activates the Sirt-1/PGC-1 pathway
to promote browning of 3T3-L1 adipocytes, as shown in
Fig. 9.
Piantadosi et al. demonstrated that Nrf2 connects mito-
chondrial biogenesis with antioxidant defenses via the mul-
tiple Nrf2 binding sites in the NRF-1 promoter [20]. Car-
bon monoxide, a product of heme oxygenase 1, activates
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Figure 6. Lipolysis was analyzed in
adipocytes treated with the indicated
concentrations of SFN for 48 h. (A) Rep-
resentative image of Oil RedO staining.
(B) The lipid content was quantified via
detection of absorbance at 510 nm. (C)
The glycerol content was used to re-
flect the level of lipolysis in adipocytes.
*p < 0.05, **p < 0.01 compared with
the control.
Table 1. Glycerol output of 3T3-L1 adipocytes treated with SFN
(x¯± s,n= 3)
SFN (M) Glycerol content (mM)
0 0.798 ± 0.042
0.2 0.913 ± 0.060*
0.5 0.921 ± 0.056†
1.0 1.032 ± 0.045†
5.0 0.966 ± 0.017†
10.0 0.916 ± 0.056*
The results are presented as means ± SD of three independent
experiments.
*p < 0.05, †p < 0.01, compared with control.
mitochondrial biogenesis in cardiomyocytes in an Nrf2-
dependent manner. In detail, carbon monoxide elevated mi-
tochondrial H2O2 production, which induced Nrf2 nuclear
translocationmediated byPKB/Akt kinase [21] andoccupancy
of four AREs in the NRF-1 promoter, thereby leading to gene
activation for mitochondrial biogenesis. SFN is a well-known
and potent activator of Nrf2. In the present study, SFN was
found to enhance Nrf2 protein expression. Of note, the effect
of SFN on the browning of adipocytes occurred in a different
manner with the most marked effect observed at a relative
low dose (1 M). It is still reasonable, however, to assume
that Nrf2 is involved in the browning effect of SFN on 3T3-L1
adipocytes.
Detailed understanding of how glucose and lipid
metabolism occur in beige fat cells is critical for the iden-
tification and implementation of brown fat-based therapies
for obesity and related disease. Accumulating evidence sup-
ports the notion that themetabolic benefits of this conversion
from white to beige cells include prevention of diet-induced
obesity and increase of insulin (INS) sensitivity [22], given
that mitochondria are the central players in cellular bioen-
ergetics and global metabolism homeostasis. Unfortunately,
we lack sufficient details with respect to glucose and lipid dis-
posal capacity of beige adipocytes. Therefore, we determined
whether glucose and lipid utilization altered in SFN-treated
adipocytes that displayed a beige phenotype with enhanced
mitochondrial biogenesis. Disruption in glucose homeosta-
sis causes diseases such as diabetesmellitus and cardiovascu-
lar disorders, and glucose transporters mediate the transport
of glucose from the extracellular fluid into the cytoplasm of
mammalian cells [23]. The GLUT-4 system, which is mainly
expressed in skeletal muscle and fat cells, is a pivotal com-
ponent in the maintenance of glucose homeostasis, and this
system has been widely studied due to its role in diabetes
[24]. Adipose is a metabolically meaningful tissue and capa-
ble of contributing to whole-body glucose homeostasis. In
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Figure 7. Effect of SFN on expression of lipolysis-related enzymes in adipocytes. Mature adipocytes were treated with indicated doses of
SFN for 48 h. Total protein extracts were prepared, and levels of ATGL, Plin, HSL, p-HSLSer563, p-HSLSer565, and p-HSLSer660 were analyzed
by Western blot. (A) Representative image of Western blot. (B–C) Relative quantification of protein levels. Results are presented as the
percentages relative to the control. The results are presented as means ± SD of three independent experiments. *p < 0.05, **p < 0.01
compared with the control.
INS-resistant humans and rodents, the expression of GLUT-
4 is decreased in adipocytes compared to muscle [25]. Con-
versely, GLUT-4 over-expression in adipose tissue of mice
lacking GLUT-4 selectively in muscle reverses INS resistance
and diabetes [26]. While increased GLUT-4-mediated glucose
transport plays a rate-limiting role in glucose utilization in
adipose tissues [27], Heiss et al. reported that small molecule
SFN increased cellular glucose uptake in mouse embryonic
fibroblasts [28]. Consistent with these findings, we detected
an enhanced cellular uptake of glucose analog 2-NBDG and a
high level of GLUT-4 expression in 3T3-L1 adipocytes treated
with SFN, indicating that SFN acts to stimulate glucose up-
take via upregulation of GLUT-4 in these cells. As a major
energy source, glucose provides energy in the form of ATP
via glycolysis and the citric acid cycle. We used detection of
the levels of GCK and CS, key enzymes of glycolysis and tri-
carboxylic acid cycle, respectively, to track the metabolic fate
of glucose in SFN-treated adipocytes. SFN markedly elevated
the expressions of GCK and CS, and thus, we propose that
SFN treatment enhances mitochondrial biogenesis, thereby
promoting upregulation of glucose aerobic oxidation path-
way.
We also investigated the effect of browning of 3T3-L1
adipocytes on lipid metabolism. As for lipolysis, ATGL,
which is located on the surface of lipid droplets, specifically
removes the first FA from the TG molecule generating DAG
[29]. HSL then acts to convert DAG into monoacylglycerol.
Of note, TG in adipocytes is stored within lipid droplets
surrounded by a phospholipid monolayer containing various
lipid droplet proteins, and lipolysis involves specific protein–
protein interactions at the surface of these lipid droplets
[30]. Plin is a lipid droplet scaffold protein and is known
as a “molecular switch” of lipolysis [31]. Plin functions to
protect lipid storage droplets in adipocytes by coating them
until digestion by HSL and promoting interactions amongst
lipolytic effector proteins, thereby modulating the lipid
metabolism in adipocytes [31, 32]. In the basal state, Plin
sequesters /-fold domain-containing protein 5, causing
the inactivation of ATGL [33]. Catecholamines stimulate the
phosphorylation of cytosolic HSL and Plin via PKA, resulting
in release of /-fold domain-containing protein 5, which
is then available for ATGL. Finally, TG hydrolysis is initiated
[34]. As a critical regulator of lipolysis, elevated Plin levels
have been linked to obesity, and by contrast, downregulation
of Plin expression either with or without upregulation of
p-Plin results in destruction of the protein protective barrier
on the surface of the lipid droplet and enhancement of
lipolysis [33]. For example, enhanced expression of Plin is
necessary for the antilipolytic effect of activator minoimi-
dazole carboxamide ribonucleotide [32]. As the rate-limiting
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Figure 8. Effect of SFN on FA oxidation and triglyceride synthesis in adipocytes. Mature adipocytes were treated with different concen-
trations of SFN for 48 h. Total protein extracts were prepared, and protein levels of CPT1A, CS (key enzyme in FA aerobic oxidation),
and DGAT-1 (key enzyme in triglyceride synthesis) were analyzed by Western blot. (A) CPT1A and CS expression. Upper: representative
image of Western blot. Lower: quantification of CPT1A and CS protein expression. (B) DGAT-1 expression. Upper: representative image of
Western blot. Lower: quantification of DGAT-1 protein expression. Results are presented as percentages relative to the control. Values are
means ± SD of three independent experiments. *p < 0.05, **p < 0.01 compared with the control.
Figure 9. Proposed schematic diagram of SFN-induced mito-
chondrial biogenesis. SFN activates the Sirt-1/PGC-1 pathway
and enhances expression of Nrf2 and NRF-1, thereby promoting
the expressions of genes involved in mitochondrial biogenesis
and triggering browning of 3T3L1 adipocytes.
enzyme for the lipolysis reaction [35], HSL is a major target
of PKA-catalyzed lipolysis [36], which results in phosphory-
lation and activation of HSL at Ser 563, Ser 659, and Ser 660
[37]. Conversely, phosphorylation of HSL at Ser 565 inhibits
the phosphorylation of HSL at Ser 563 by PKA. A recent
study by Lee et al. showed that SFN increased lipolysis via an
increase in HSL phosphorylation at Ser 563 and suppression
of phosphorylation at Ser 565 without any detectable effect
on Plin mRNA [12]. In our study, SFN decreased the cellular
lipid droplet loads and suppressed the protein expression of
Plin. One possible explanation for the discrepancy between
levels of Plin expression in these two studies may be that our
study employed a longer SFN treatment time (48 h) than the
one (24 h) used in the study by Lee et al. Our results also
demonstrated that SFN significantly upregulates HSL at the
protein level in adipocytes, stimulates the phosphorylation of
HSL at Ser 563 and Ser 660, and inhibits the phosphorylation
of HSL at Ser 565. Interestingly, a previous study showed
that ATGL-catalyzed lipolysis induced PGC-1 signaling and
downstream changes in oxidative metabolism [38]; yet, in
our study, SFN elevated, but did not significantly increased,
the expression of ATGL. Therefore, we postulate that the
SFN-induced lipolysis enhancement may be most dependent
on the activation of HSL, as ATGL was not involved in
the effect of SFN on PGC-1 signaling or on oxidative
metabolism.
In general, the FAs derived from lipolysis in adipocytes
are available for -oxidation or reassembly for storage as in-
ert triglycerides via lipogenesis. To describe themetabolic fate
of FAs, we measured the levels of CPT1A and CS, which are
responsible for the influx of FAs intomitochondria and in ad-
vancement of the citric acid cycle, and the protein expression
of DGAT-1, which catalyzes the final step of TG synthesis
[39]. DGAT-1 is present in adipose tissues and is believed to
play a role in lipid absorption and accumulation in the fat
cells. A previous report showed that transgenic overexpres-
sion ofDGAT-1 in adipose tissues resulted inwhole-body INS
resistance and other metabolic disturbances, suggesting that
inhibition of DGAT-1 is a promising target for the treatment
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Figure 10. Effect of SFN on glucose and lipid metabolism in ma-
ture 3T3-L1 adipocytes. SFN enhances glucose uptake and aer-
obic oxidation by upregulating expression of GLUT-4, GCK, and
CS proteins. SFN also increases lipolysis by upregulating the lev-
els of key enzymes, such as HSL and its phosphorylated form
p-HSLSer563 and p-HSLSer660, involved in lipid hydrolysis, and by
inhibiting levels of Plin. Furthermore, SFN triggers FA oxidation
by increasing the levels of the enzymes CPT1A and CS, which
are responsible for FA -oxidation. In contrast, SFN also inhibits
endogenous FA and triglyceride synthesis by downregulating the
levels of ACC and FAS as well as DGAT-1.
of obesity and type 2 diabetes [40]. Furthermore, our results
demonstrated that SFN significantly increases CPT1A and
CS protein levels and simultaneously decreases the expres-
sion of DGAT-1, suggesting that more FAs released by SFN-
enhanced lipolysis may enter the aerobic oxidation pathway
than the triglyceride synthesis pathway.
In addition, acetyl-CoA, a product of the -oxidation of
FAs, can be used to synthesize FAs through a complex set
of reaction. This process, termed de novo FA synthesis,
requires two major enzymatic steps. First, ACC catalyzes
the synthesis of malonyl-CoA from acetyl-CoA, and then
FAS sequentially condenses acetyl-CoA and malonyl-CoA to
build up long-chain FAs. In the current study, SFNmarkedly
inhibited the expressions of both ACC and FAS, in favor of
decreasing de novo FA synthesis. Therefore, the browning of
adipocytes induced by SFN may be favorable for whole-body
lipid metabolism based on evidence that this compound
significantly reduced the lipid droplet load, significantly
increased the gene expressions related to -oxidation of
FAs, and significantly decreased the levels of key enzyme
involved in synthesis of TG. At the same time, the de novo
FA synthesis-related protein expression was downregulated.
Taken together, these data suggest that SFN-induced
browning of adipocytes is favorable for the conversion of
adipose tissue from an energy storage site to a lipid burn site
(Fig. 10).
5 Conclusion
Phytochemicals are types of active components from natural
plants with many biological functions. Therefore, it comes as
no surprise that phytochemicals are a valuable resources for
antiobesity drug development. Our study for the first time
demonstrated that SFN functions to induce the browning
of 3T3-L1 adipocytes and that this alteration is character-
ized by the elevated level and function of mitochondria, as
well as the increased expression of UCP1. More importantly,
this study systematically evaluated the effect of browning of
adipocytes on glucose and lipid metabolism pathway at the
cellular level, and revealed that SFN upregulates glucose up-
take and oxidative utilization as well as lipolysis and FA oxi-
dation pathway, while suppresses the endogenous synthesis
of TGs pathway. Moreover, the upregulated UCP1 expres-
sion leads to dispersion of energy as heat and the decrease
in ATP level. Taken together, these findings support the no-
tion that browning of adipocytes triggered by SFN promotes
glucose and lipid utilization in adipocytes, is favourable for
improving of whole-body metabolic load, and therefore, may
be considered as an appealing strategy for addressing obesity
and obesity-related diseases. Furthermore, clinical investiga-
tion is necessary to determine the potential of SFN to prevent
obesity-related metabolism disorder in humans by inducing
adipocyte browning.
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